Trevena is an innovative biopharmaceutical company based in Upper Merion Township, PA, dedicated to developing groundbreaking medicines for patients with central nervous system disorders. Their pipeline includes one FDA-approved product, OLINVYK oliceridine injection, and three investigational drug candidates based on Nobel Prize-winning research.
With a focus on targeted and innovative CNS therapies, Trevena's novel pipeline addresses critical needs in areas such as acute pain, diabetic neuropathic pain, epilepsy, acute migraine, and opioid use disorder. Their commitment to delivering effective treatments is evident in their ongoing research and development efforts.
Generated from the website